Lung neuroendocrine cancer induces immunosuppressive macrophages via serotonin to drive resistance to the T cell engager tarlatamab
Cancer Cell · 2026-11 · 44 (11) · 2154-2172.e11
DOI: 10.1016/j.ccell.2026.09.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2026-11. Verfasst von Kotaro Nomura und 39 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Immunology, Research Institute, National Cancer Center, Tokyo, Japan; Department of Thoracic Surgery, National Cancer Center Hospi…. Hauptthemen laut MEDLINE: Serotonin, Lung Neoplasms, Drug Resistance, Neoplasm, Tumor-Associated Macrophages. Die Arbeit nennt 66 Literaturangaben. Gefördert von: Kobayashi Foundation for Cancer Research, Mitsubishi Foundation, Pharmaceutical Society of Japan.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cancer Immunology, Research Institute, National Cancer Center, Tokyo, Japan; Department of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan; Department of General Thoracic Surger…
- Division of Cancer Immunology, Research Institute, National Cancer Center, Tokyo, Japan; Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka, Japan.
- Division of Cancer Immune Multicellular System Regulation, Center for Cancer Immunotherapy and Immunobiology, Kyoto, Japan.
- Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- Division of Cancer Immunology, Research Institute, National Cancer Center, Tokyo, Japan.
- Division of Cancer Immunology, Research Institute, National Cancer Center, Tokyo, Japan; Department of Immunogenomic Medicine, Research Institute, National Cancer Center, Tokyo, Japan.
Förderung
- Kobayashi Foundation for Cancer Research
- Mitsubishi Foundation
- Pharmaceutical Society of Japan
- Chugai Foundation for Innovative Drug Discovery Science
- The Hitachi Global Foundation
- Princess Takamatsu Cancer Research Fund
- Daiichi Sankyo Foundation of Life Science
- The Japan Lung Cancer Society
Zitieren
APA
Nomura, K., Fukami, T., Kato, S., Tanaka, S., Fukuda, A., Koike, Y., Kondo, M., Kumagai, K., Irie, T., Okumura, G., Taki, T., Sakashita, S., Shirasawa, M., Yoshida, T., Shiraishi, K., Ariyasu, R., Takeyasu, Y., Niimi, T., Sakai, T., …, & Nishikawa, H. (2026). Lung neuroendocrine cancer induces immunosuppressive macrophages via serotonin to drive resistance to the T cell engager tarlatamab. Cancer Cell, 44(11), 2154-2172.e11. https://doi.org/10.1016/j.ccell.2026.09.016
Vancouver
Nomura K, Fukami T, Kato S, Tanaka S, Fukuda A, Koike Y, et al. Lung neuroendocrine cancer induces immunosuppressive macrophages via serotonin to drive resistance to the T cell engager tarlatamab. Cancer Cell. 2026;44(11):2154-2172.e11. doi:10.1016/j.ccell.2026.09.016
BibTeX
@article{Nomura2026,
author = {Nomura, Kotaro and Fukami, Tomoyo and Kato, Shinichiro and Tanaka, Shunya and Fukuda, Akito and Koike, Yuki and Kondo, Masaki and Kumagai, Kazuhiro and Irie, Takuma and Okumura, Genki and Taki, Tetsuro and Sakashita, Shingo and Shirasawa, Masayuki and Yoshida, Tatsuya and Shiraishi, Kouya and Ariyasu, Ryo and Takeyasu, Yuki and Niimi, Takahiro and Sakai, Tetsuya and Torasawa, Masahiro and Kanemura, Hiroaki and Saito, Shin and Hayashi, Takuo and Kanai, Akinori and Takamochi, Kazuya and Haruki, Tomohiro and Aokage, Keiju and Nishinakamura, Hitomi and Koyama, Shohei and Ishii, Genichiro and Suzuki, Yutaka and Goto, Yasushi and Nishio, Makoto and Suzuki, Kenji and Tsutani, Yasuhiro and Yatabe, Yasushi and Mano, Hiroyuki and Tsuboi, Masahiro and Kumagai, Shogo and Nishikawa, Hiroyoshi},
title = {Lung neuroendocrine cancer induces immunosuppressive macrophages via serotonin to drive resistance to the T cell engager tarlatamab},
journal = {Cancer Cell},
year = {2026},
volume = {44},
number = {11},
pages = {2154--2172.e11},
doi = {10.1016/j.ccell.2026.09.016}
}
EUVIMED